These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2824009)

  • 1. Receptors in the basal ganglia.
    Guttman M
    Can J Neurol Sci; 1987 Aug; 14(3 Suppl):395-401. PubMed ID: 2824009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pattern of neurodegeneration in Huntington's disease: a comparative study of cannabinoid, dopamine, adenosine and GABA(A) receptor alterations in the human basal ganglia in Huntington's disease.
    Glass M; Dragunow M; Faull RL
    Neuroscience; 2000; 97(3):505-19. PubMed ID: 10828533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations of neurotransmitter receptors and neurotransmitter transporters in progressive supranuclear palsy.
    Landwehrmeyer B; Palacios JM
    J Neural Transm Suppl; 1994; 42():229-46. PubMed ID: 7525868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurotransmitter receptor alterations in Huntington's disease: autoradiographic and homogenate studies with special reference to benzodiazepine receptor complexes.
    Whitehouse PJ; Trifiletti RR; Jones BE; Folstein S; Price DL; Snyder SH; Kuhar MJ
    Ann Neurol; 1985 Aug; 18(2):202-10. PubMed ID: 2994554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parkinson's disease: nigral receptor changes support peptidergic role in nigrostriatal modulation.
    Uhl GR; Hackney GO; Torchia M; Stranov V; Tourtellotte WW; Whitehouse PJ; Tran V; Strittmatter S
    Ann Neurol; 1986 Aug; 20(2):194-203. PubMed ID: 3019228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GABA and benzodiazepine receptors in basal ganglia function.
    Young AB; Pan HS; Ciliax BJ; Penney JB
    Neurosci Lett; 1984 Jun; 47(3):361-7. PubMed ID: 6089057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurotensin, substance P, delta and mu opioid receptors are decreased in basal ganglia of Parkinson's disease patients.
    Fernandez A; de Ceballos ML; Jenner P; Marsden CD
    Neuroscience; 1994 Jul; 61(1):73-9. PubMed ID: 7969897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Receptor autoradiography as a tool for the study of the phylogeny of the basal ganglia.
    Dietl M; Palacios JM
    J Recept Res; 1988; 8(1-4):521-32. PubMed ID: 2838628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain neurotransmitters and neuropeptides in Parkinson's disease.
    Rinne UK; Rinne JO; Rinne JK; Laakso K; Lönnberg P
    Acta Physiol Pharmacol Latinoam; 1984; 34(3):287-99. PubMed ID: 6099688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relative involvement of globus pallidus and subthalamic nucleus in the regulation of somatodendritic dopamine release in substantia nigra is dopamine-dependent.
    Cobb WS; Abercrombie ED
    Neuroscience; 2003; 119(3):777-86. PubMed ID: 12809698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations in cortical and basal ganglia levels of opioid receptor binding in a rat model of l-DOPA-induced dyskinesia.
    Johansson PA; Andersson M; Andersson KE; Cenci MA
    Neurobiol Dis; 2001 Apr; 8(2):220-39. PubMed ID: 11300719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of dopamine receptor and neuropeptide expression in the basal ganglia of monkeys treated with MPTP.
    Betarbet R; Greenamyre JT
    Exp Neurol; 2004 Oct; 189(2):393-403. PubMed ID: 15380489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in benzodiazepine and acetylcholine receptors in the globus pallidus in Parkinson's disease.
    Griffiths PD; Sambrook MA; Perry R; Crossman AR
    J Neurol Sci; 1990 Dec; 100(1-2):131-6. PubMed ID: 1965202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on neurotransmitter markers and striatal neuronal cell density in Huntington's disease and dentatorubropallidoluysian atrophy.
    Kanazawa I; Sasaki H; Muramoto O; Matsushita M; Mizutani T; Iwabuchi K; Ikeda T; Takahata N
    J Neurol Sci; 1985 Sep; 70(2):151-65. PubMed ID: 2865338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurotransmitter receptor mapping by autoradiography and other methods.
    Kuhar MJ; De Souza EB; Unnerstall JR
    Annu Rev Neurosci; 1986; 9():27-59. PubMed ID: 2423006
    [No Abstract]   [Full Text] [Related]  

  • 16. GABAergic neurotransmission in globus pallidus and its involvement in neurologic disorders.
    Chen L; Yung WH
    Sheng Li Xue Bao; 2004 Aug; 56(4):427-35. PubMed ID: 15322674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of unilateral 6-hydroxydopamine lesions of the nigrostriatal pathway on GABA(A) receptor subunit gene expression in the rodent basal ganglia and thalamus.
    Chadha A; Dawson LG; Jenner PG; Duty S
    Neuroscience; 2000; 95(1):119-26. PubMed ID: 10619468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple benzodiazepine receptors in the human basal ganglia: a detailed pharmacological and anatomical study.
    Faull RL; Villiger JW
    Neuroscience; 1988 Feb; 24(2):433-51. PubMed ID: 2834664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alzheimer's disease: changes in hippocampal N-methyl-D-aspartate, quisqualate, neurotensin, adenosine, benzodiazepine, serotonin and opioid receptors--an autoradiographic study.
    Jansen KL; Faull RL; Dragunow M; Synek BL
    Neuroscience; 1990; 39(3):613-27. PubMed ID: 1965859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The distribution of excitatory amino acid receptors in the normal human midbrain and basal ganglia with implications for Parkinson's disease: a quantitative autoradiographic study using [3H]MK-801, [3H]glycine, [3H]CNQX and [3H]kainate.
    Ball EF; Shaw PJ; Ince PG; Johnson M
    Brain Res; 1994 Sep; 658(1-2):209-18. PubMed ID: 7834343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.